Suchergebnisse - "Kim, Yeon Sook"

PubPharm (299)

1

Incidence of Clostridioides difficile Infections in Republic of Korea : A Prospective Study With Active Surveillance vs. National Data From Health Insurance Review & Assessment Service

enthalten in: Journal of Korean medical science | 2024

von Kim, J. | Myung, R. | Kim, B. | +19

2

Rise in broadly cross-reactive adaptive immunity against human β-coronaviruses in MERS-recovered patients during the COVID-19 pandemic

enthalten in: Science advances | 2024

von Kim, S. | Kim, Y. | Jeon, S. | +18

3

Asian participants' experience in phase 3/3b studies of long-acting cabotegravir and rilpivirine : Efficacy, safety, pharmacokinetic, and virological outcomes through week 96

enthalten in: HIV medicine | 2024

von Oka, S. | Holohan, V. | Shirasaka, T. | +13

4

Asian participants' experience in phase 3/3b studies of long‐acting cabotegravir and rilpivirine : Efficacy, safety, pharmacokinetic, and virological outcomes through week 96

enthalten in: HIV Medicine | 2024

von Oka, S. | Holohan, V. | Shirasaka, T. | +13

5

Molecular Typing on Human Blood Reveals the Borrelia afzelii Infection in Korea

enthalten in: Infection & chemotherapy | 2023

von Kim, Y. | Kim, J. | Choi, Y. | +3

6

Polarized Lung Inflammation and Tie2/Angiopoietin-Mediated Endothelial Dysfunction during SevereOrientia tsutsugamushiInfection

enthalten in: bioRxiv.org | 2023

von Trent, B. | Liang, Y. | Xing, Y. | +11

7

A Korean Post-Marketing Study of Abacavir/Dolutegravir/Lamivudine in Patients with HIV-1

enthalten in: Infection & chemotherapy | 2023

von Shin, S. | Cho, J. | Lee, E. | +2

CommentIn: Infect Chemother. 2024 Mar;56(1):96-97. - PMID 38527777

8

Distinctive Dynamics and Functions of the CD4+CD25+FOXP3+ Regulatory T Cell Population in Patients with Severe and Mild COVID-19

enthalten in: Journal of immunology (Baltimore, Md. : 1950) | 2023

von Nam, H. | Koh, J. | Jung, J. | +6

9

Corticosteroids reduce pathologic interferon responses by downregulating STAT1 in patients with high-risk COVID-19

enthalten in: Experimental & molecular medicine | 2023

von Jeong, H. | Lee, J. | Ko, J. | +9

10

Corrigendum : Elevated IFNA1 and suppressed IL12p40 associated with persistent hyperinflammation in COVID-19 pneumonia

enthalten in: Frontiers in immunology | 2023

von Jeon, K. | Kim, Y. | Kang, S. | +27

ErratumFor: Front Immunol. 2023 Jan 27;14:1101808. - PMID 36776879

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[30]